Lynch's bill cited the large number of overdose deaths and addiction cases associated with the drug, but the measure was criticized by a spokesperson for Purdue Pharma, the maker of OxyContin.

"We absolutely share a concern that the illegal use of this drug is a serious problem in the Boston area," said Robin Hogen, the pharmaceutical firm's vice president of public affairs. "It is not, however, a national problem. If you take it off the market because it is being abused ... you're really allowing criminals to dictate healthcare policy."

Some local healthcare workers and pain patients praised the drug, and Hogen predicted that Lynch's office would be flooded by calls and letters from others seeking to prevent a ban on OxyContin.

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (read guidelines):

Name:
Comment: (limit 200 words)
Enter this word (help):	Change

GUIDELINES: 
To keep this feature useful for all, please:

1. Keep it clean, courteous, and on-topic. Comments are meant for thoughtful discussion of the article published above.
   
   
2. Do not post promotional links to organizations, products or services, or personal requests for assistance (get help).
   
   
3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercially-motivated posts are prohibited. We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.